phenylalanine has been researched along with Rhabdomyosarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauwens, M; Bossuyt, A; Kersemans, K; Keyaerts, M; Lahoutte, T; Mertens, J; Peleman, C; Snykers, S; Vinken, M; Wimana, L | 1 |
| Hsu, JT; Hung, HC; Shih, SR; Teng, IF; Tseng, CP; Wang, HC | 1 |
| Bauwens, M; Bossuyt, A; Joos, C; Kersemans, V; Lahoutte, T; Mertens, J; Slegers, G | 1 |
| Achten, E; Bauwens, M; Cornelissen, B; Dierckx, RA; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G | 1 |
| Bacher, K; Cornelissen, B; De Spiegeleer, B; Dierckx, RA; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G; Thierens, H | 1 |
| Cornelissen, B; De Spiegeleer, B; Dierckx, RA; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G | 1 |
| De Spiegeleer, B; Kersemans, V; Mertens, J; Slegers, G | 1 |
| Bauwens, M; Bossuyt, A; Caveliers, V; Kersemans, K; Lahoutte, T; Mertens, J | 1 |
| Dayto, GO; Langdon, E; Rochlin, D | 1 |
| Dayton, GO; Langdon, E; Rochlin, D | 1 |
1 review(s) available for phenylalanine and Rhabdomyosarcoma
| Article | Year |
|---|---|
Management of orbital rhabdomyosarcoma.
Topics: Chemotherapy, Cancer, Regional Perfusion; Child; Dactinomycin; Humans; Male; Orbital Neoplasms; Phenylalanine; Rhabdomyosarcoma | 1969 |
9 other study(ies) available for phenylalanine and Rhabdomyosarcoma
| Article | Year |
|---|---|
Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
Topics: Animals; Humans; Iodine Radioisotopes; Luciferases; Luminescent Measurements; Mice; Mice, Nude; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir.
Topics: Algorithms; Animals; Antiviral Agents; Blotting, Western; Chlorocebus aethiops; DNA Primers; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Enterovirus A, Human; Enterovirus Infections; Humans; Interferon-alpha; Interferon-Stimulated Gene Factor 3, gamma Subunit; Isoxazoles; Phenylalanine; Polymerase Chain Reaction; Pyrrolidinones; Recombinant Proteins; Rhabdomyosarcoma; Tumor Cells, Cultured; Valine; Vero Cells; Virus Replication | 2011 |
Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.
Topics: Algorithms; Animals; Buffers; Cell Line, Tumor; Half-Life; Indicators and Reagents; Neoplasm Proteins; Phenylalanine; Quality Control; Radiopharmaceuticals; Rats; Rhabdomyosarcoma; Tomography, Emission-Computed, Single-Photon | 2004 |
In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Tissue Distribution | 2005 |
In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Cluster Analysis; Disease Models, Animal; Evaluation Studies as Topic; Humans; Image Processing, Computer-Assisted; Inflammation; Iodine Radioisotopes; Kinetics; Male; Mice; Mice, Nude; Phenylalanine; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Time Factors; Tomography, Emission-Computed, Single-Photon | 2005 |
Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Topics: Animals; Cell Line, Tumor; Female; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Monoiodotyrosine; Organ Specificity; Phenylalanine; Radiopharmaceuticals; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2006 |
Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
Topics: Animals; Artifacts; Cell Line, Tumor; Disease Models, Animal; Hypnotics and Sedatives; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Pentobarbital; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution | 2006 |
D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.
Topics: Animals; Iodine Radioisotopes; Pharmacokinetics; Phenylalanine; Rats; Rhabdomyosarcoma; Tyrosine | 2007 |
Management of orbital rhabdomyosarcoma.
Topics: Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Dactinomycin; Head and Neck Neoplasms; Humans; Lymph Nodes; Neck Dissection; Neoplasm Recurrence, Local; Orbital Neoplasms; Phenylalanine; Rhabdomyosarcoma | 1969 |